Trials / Sponsors / Megan Daly, MD
Megan Daly, MD
Academic / Other · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | UCDCC#272: IL-2, Radiotherapy, and Pembrolizumab in Patients Refractory to Checkpoint Blockade Non Small Cell Lung Cancer, Metastatic Melanoma, Metastatic Renal Cell Carcinoma | Phase 1 / Phase 2 | 2019-05-20 |
| Completed | Atezolizumab and Stereotactic Body Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer Stage I Non-Small Cell Lung Cancer | Phase 1 | 2018-04-26 |
| Completed | UCDCC#270: Avelumab and Stereotactic Ablative Radiotherapy in Non-responding and Progressing NSCLC Patients Metastatic Non-small Cell Lung Cancer (NSCLC) | EARLY_Phase 1 | 2017-05-17 |
| Completed | TG4010 and Nivolumab in Patients With Lung Cancer Recurrent Non-Small Cell Lung Carcinoma, Stage I Non-Small Cell Lung Cancer, Stage II Non-Small Cell Lung Cancer | Phase 2 | 2016-12-14 |
| Terminated | MPDL3280A and Stereotactic Ablative Radiotherapy in Patients With Non-small Cell Lung Cancer Recurrent Non-Small Cell Lung Carcinoma, Stage IV Non-Small Cell Lung Cancer | Phase 1 | 2015-12-03 |